GoHearing Ultra vs Resound Vivia 9 60S microRIE

The GoHearing Ultra is a budget-priced OTC behind-the-ear hearing aid that earned a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable tier of OTC devices, though its overall performance ranks 58th out of 65 OTC hearing aids tested. This device shows a distinctive performance profile with notable strengths in specific areas. Feedback handling earned an excellent 5.0/5, scoring 0.46 points above the category average—meaning users are unlikely to experience whistling or squealing during typical use. Music streaming also performed well at 3.6/5, a solid score that sits 1.68 points above the OTC average of 1.92/5, making it a reasonable choice for those who prioritize phone audio streaming. However, the GoHearing Ultra struggles in core speech understanding metrics. Speech in quiet scored just 1.0/5, falling 1.79 points below the category average, while speech in noise also scored 1.0/5, sitting 0.48 points below average. Own-voice comfort measured 1.9/5, which is 0.61 points below the typical OTC device. These low speech scores significantly limit the device's utility for its primary purpose of improving conversation clarity. Consumers seeking better overall value in this price range may want to consider alternatives like the Elehear Beyond (4.36/5) or Apple AirPods Pro 2 (4.06/5), which deliver substantially stronger speech performance. The GoHearing Ultra may suit buyers who prioritize streaming audio and feedback-free wear over speech enhancement, but those seeking meaningful speech benefit should explore higher-performing options.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.